Mantle Cell Lymphoma
Showing NaN - NaN of 20
Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,
Not yet recruiting
- Non-hodgkin Lymphoma
- +9 more
- CD79b-19 CAR T cells
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 6, 2023
Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma Trial in Boston (Adaptive Bridging Radiation Therapy (ABRT))
Not yet recruiting
- Lymphoma, B-Cell
- +7 more
- Adaptive Bridging Radiation Therapy (ABRT)
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 16, 2023
CD20 Positive, Mantle Cell Lymphoma Trial in United States (procedure, other, biological)
Recruiting
- CD20 Positive
- Mantle Cell Lymphoma
- Autologous Hematopoietic Stem Cell Transplantation
- +2 more
-
Birmingham, Alabama
- +318 more
Jan 3, 2023
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (TGR-1202, Ibrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Mantle Cell Lymphoma
-
Monterey, California
- +4 more
Aug 29, 2022
Mantle Cell Lymphoma, Refractory Lymphoma Trial in Boston (Acalabrutinib, Venetoclax, Obinutuzumab)
Recruiting
- Mantle Cell Lymphoma
- Refractory Lymphoma
- Acalabrutinib
- +2 more
-
Boston, Massachusetts
- +1 more
Aug 8, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)
Enrolling by invitation
- Chronic Lymphocytic Leukemia
- +6 more
-
Duarte, California
- +165 more
Mar 24, 2022
Collecting and Storing Tissue Samples From Rare or Cutaneous
Active, not recruiting
- Adult Immunoblastic Lymphoma
- +12 more
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +129 more
Mar 23, 2022
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
Mantle Cell Lymphoma Trial in United States (bortezomib)
Active, not recruiting
- Mantle Cell Lymphoma
-
San Francisco, California
- +47 more
Aug 16, 2021
Mantle Cell Lymphoma Trial in Boston (Rituximab, Bendamustine, Cytarabine)
Active, not recruiting
- Mantle Cell Lymphoma
- Rituximab
- +2 more
-
Boston, Massachusetts
- +2 more
Jun 9, 2021
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib
Terminated
- Chronic Lymphocytic Leukemia
- +4 more
- Entospletinib MM
- Entospletinib SDD
-
Birmingham, Alabama
- +47 more
Nov 2, 2020
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +9 more
-
Stanford, California
- +15 more
May 14, 2020
Patients Previously Treated With a Juno CAR T-Cell Product
Terminated
- Non Hodgkin Lymphoma
- +5 more
- JCAR017
- JCARH125
-
Duarte, California
- +1 more
Apr 30, 2020